Abstract
Complement's role in SLE pathology is not limited to tissue damage at immune complex deposition sites. Circulating split products can cause inflammatory cells to occlude small vessels and damage their endothelium—all in the absence of IC deposition. In SLE, split-product levels reflect disease activity and predict flares better than conventional complement measurements.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
